Results 181 to 190 of about 132,532 (337)

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Subsets of midbrain dopamine (DA) neurons express the vesicular glutamate transporter VGLUT2 and can release the excitatory neurotransmitter glutamate. VGLUT2+ DA neurons of the substantia nigra pars compacta (SNc) were shown to be more resistant to neurodegeneration in animal models of Parkinson's disease (PD ...
Sivakumar Srinivasan, Christian Pifl, Thomas Steinkellner   +2 more
wiley   +1 more source

Deep-learning segmentation of the substantia nigra from multiparametric MRI: Application to Parkinson's disease. [PDF]

Imaging Neurosci (Camb)
Lillebostad PAG, Njølstad TH, Hogstad S, Riemer F, Kverneng SU, Stige KE, Biermann M, Jog M, Buch S, Haacke EM, Tzoulis C, Lundervold A.   +11 more
europepmc   +1 more source

Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers

European Journal of Clinical Investigation, EarlyView.
This review outlines positron emission tomography (PET) biomarkers used in Alzheimer's disease (AD) research and clinical settings, targeting both specific (amyloid, tau) and non‐specific (neurodegeneration, synaptic density, neuroinflammation) processes.
Elif Harput, Cecilia Boccalini, Gregory Mathoux, John O. Prior, Nathalie Testart, Mario Jreige, Valentina Garibotto   +6 more
wiley   +1 more source

A Spatially Resolved View on the Aging Substantia nigra: An Exploratory Proteomic Study. [PDF]

Adv Biol (Weinh)
Eggers B, Hausherr M, Lim M, Schork K, Karacora B, Grugel R, Eisenacher M, Aldea IG, Riederer P, Gerlach M, Marcus K.   +10 more
europepmc   +1 more source

Effects of cell therapy on seizures in animal models of epilepsy: Systematic review and meta‐analysis

Epilepsia, EarlyView.
Abstract This study was undertaken to systematically evaluate the efficacy of cell therapy in reducing seizures in animal models of chronic epilepsy. Three databases, Ovid MEDLINE, Ovid Embase, and Web of Science, were searched using predetermined eligibility criteria.
Afaf S. Altalhi, Muhammad S. Javaid, Nigel C. Jones, Kim L. Powell, Patrick Kwan, Terence J. O'Brien, Ana Antonic‐Baker   +6 more
wiley   +1 more source

Clinical and Genetic Characteristics of Parkinson's Disease Patients with Substantia Nigra Hyperechogenicity. [PDF]

Int J Mol Sci
Milanowski Ł, Szukało P, Kowalska M, Sikorska A, Hoffman-Zacharska D, Koziorowski D.   +5 more
europepmc   +1 more source

Akinetic mutism in a patient with acute infarcts in the bilateral substantia nigra

, 2016
Hyun Ah Kim, Sooyeoun You
openalex   +2 more sources

Restoring failed inhibition in the substantia nigra pars reticulata suppresses absence seizures in rats

Epilepsia, EarlyView.
Abstract Objective For over four decades, the substantia nigra pars reticulata (SNr) has been recognized as a critical structure in the modulation of seizure activity. Pharmacological and optogenetic inhibition of the SNr produces robust seizure suppression in a range of seizure models.
Devin Palmer, Patrick A. Forcelli
wiley   +1 more source

Substantia nigra-related gene polymorphisms associated with acute antipsychotic-induced movement disorders. [PDF]

Mil Med Res
Hashimoto K.
europepmc   +1 more source

THE SUBSTANTIA NIGRA SOEMERINGI [PDF]

The Journal OF Nervous and Mental Disease, 1909
Julius Bauer, M. J. KARPAS
openaire   +1 more source